Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS
Acetylcysteine
/ metabolism
Acute Kidney Injury
/ chemically induced
Animals
Dose-Response Relationship, Drug
Male
Piperazines
/ metabolism
Proto-Oncogene Proteins p21(ras)
/ antagonists & inhibitors
Pyridines
/ metabolism
Pyrimidines
/ metabolism
Rats
Rats, Sprague-Dawley
Signal Transduction
/ drug effects
KRAS
Kidney toxicity
Mercapturic acid pathway
Metabolite
Sotorasib
Sprague Dawley rat
Journal
Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575
Informations de publication
Date de publication:
15 07 2021
15 07 2021
Historique:
received:
04
03
2021
revised:
12
05
2021
accepted:
13
05
2021
pubmed:
19
5
2021
medline:
23
6
2021
entrez:
18
5
2021
Statut:
ppublish
Résumé
Sotorasib is a first-in class KRAS
Identifiants
pubmed: 34004237
pii: S0041-008X(21)00185-X
doi: 10.1016/j.taap.2021.115578
pii:
doi:
Substances chimiques
Kras protein, rat
0
Piperazines
0
Pyridines
0
Pyrimidines
0
sotorasib
2B2VM6UC8G
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Acetylcysteine
WYQ7N0BPYC
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
115578Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.